Sartorius Stedim Biotech: Information on Document Availability
The issuer is solely responsible for the content of this announcement.
- The issuer is solely responsible for the content of this announcement.
- Sartorius Stedim Biotech Group’s Universal Registration Document 2023 is now available at:
It contains the following information:
- Consolidated financial statements for the year ended December 31, 2023
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. - The shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris.
- Sartorius Stedim Biotech regularly expands its portfolio through acquisitions of complementary technologies.